Poly Medicure Stock Screener | Share Price & Fundamental Analysis
POLYMED
Medical Equipment
Screen Poly Medicure share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹1776.30
▼
-0.60 (-0.03%)
Share Price BSE
₹1777.95
▲
2.00 (0.11%)
Market Cap
₹18,252.82 Cr.
P/E Ratio (TTM)
49.99
P/B Ratio
6.20
EPS (TTM)
₹34.13
Dividend Yield
0.20%
Debt to Equity
0.08
52W High
₹2835.20
52W Low
₹1706.40
Operating Margin
27.00%
Profit Margin
19.70%
Revenue (TTM)
₹467.00
EBITDA
₹146.00
Net Income
₹92.00
Total Assets
₹3,193.00
Total Equity
₹2,766.00
Poly Medicure Share Price History - Stock Screener Chart
Screen POLYMED historical share price movements with interactive charts. Analyze price trends and patterns.
Poly Medicure Company Profile - Fundamental Screener
Screen Poly Medicure company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for POLYMED shares.
Poly Medicure Limited is an Indian medical device manufacturer founded in 1995. The company produces over 130 SKUs of medical devices across various product verticals including infusion therapy, oncology, anesthesia, respiratory care, urology, gastroenterology, blood management, surgery, and dialysis. Poly Medicure operates ten manufacturing facilities across India, China, Egypt, and...more
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
Chairperson/CEO
Devendra Raj Mehta
ISIN
INE205C01021
Website
https://www.polymedicure.com
Poly Medicure Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen POLYMED balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 | 387 |
| Current Assets | 1,917 | 842 | 807 | 783 | 704 | 318 | 302 | 255 | 205 | 171 |
| Fixed Assets | 1,084 | 867 | 635 | 488 | 426 | 363 | 306 | 265 | 207 | 182 |
| Liabilities | ||||||||||
| Total Liabilities | 3,193 | 1,859 | 1,577 | 1,377 | 1,224 | 767 | 654 | 565 | 457 | 387 |
| Current Liabilities | 57 | 37 | 42 | 63 | 87 | 135 | 119 | 104 | 72 | 50 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 2,766 | 1,470 | 1,242 | 1,088 | 966 | 435 | 381 | 338 | 272 | 229 |
| Share Capital | 51 | 48 | 48 | 48 | 48 | 44 | 44 | 44 | 44 | 22 |
| Reserves & Surplus | 2,715 | 1,422 | 1,194 | 1,040 | 918 | 391 | 337 | 294 | 227 | 207 |
Screen POLYMED income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 467 | 447 | 479 | 393 | 402 | 447 | 448 | 316 | 335 | 352 | 357 | 266 | 254 | 284 | 300 |
| Expenses | 321 | 298 | 329 | 282 | 281 | 305 | 310 | 224 | 234 | 253 | 249 | 202 | 202 | 210 | 214 |
| EBITDA | 146 | 149 | 150 | 112 | 121 | 142 | 138 | 92 | 101 | 99 | 108 | 64 | 51 | 74 | 86 |
| Operating Profit % | 27.00% | 26.00% | 26.00% | 26.00% | 27.00% | 27.00% | 27.00% | 27.00% | 27.00% | 25.00% | 27.00% | 22.00% | 19.00% | 24.00% | 25.00% |
| Depreciation | 21 | 23 | 25 | 16 | 20 | 21 | 22 | 15 | 16 | 16 | 16 | 14 | 14 | 14 | 14 |
| Interest | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 4 | 2 | 1 | 0 | 5 |
| Profit Before Tax | 123 | 123 | 122 | 93 | 99 | 118 | 113 | 75 | 83 | 81 | 88 | 49 | 36 | 59 | 67 |
| Tax | 31 | 30 | 30 | 24 | 24 | 31 | 28 | 16 | 20 | 19 | 23 | 13 | 9 | 16 | 17 |
| Net Profit | 92 | 93 | 92 | 68 | 74 | 87 | 85 | 59 | 63 | 62 | 65 | 36 | 27 | 44 | 50 |
| EPS | 8.92 | 9.19 | 9.06 | 7.12 | 7.71 | 9.01 | 8.48 | 6.13 | 6.54 | 6.48 | 6.78 | 3.77 | 2.81 | 4.53 | 5.21 |
Poly Medicure Cash Flow Screener - Liquidity Fundamentals
Screen POLYMED cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 240 | 266 | 191 | 124 | 119 | 131 | 107 | 75 | 56 | 63 |
| Investing Activities | -1,194 | -241 | -179 | -85 | -436 | -110 | -101 | -88 | -56 | -31 |
| Financing Activities | 951 | -20 | -13 | -35 | 317 | -21 | -5 | 16 | 0 | -31 |
| Net Cash Flow | -3 | 5 | -1 | 3 | 0 | 1 | 1 | 3 | 0 | 1 |
Screen POLYMED shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Aug | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 62.44% | 62.44% | 62.42% | 53.15% | 66.03% | 62.56% | 62.56% | 62.44% |
| FII Holding | 11.46% | 11.41% | 9.77% | 12.38% | 9.91% | 11.10% | 11.87% | 12.33% |
| DII Holding | 11.96% | 11.72% | 13.54% | 7.22% | 9.35% | 12.48% | 12.33% | 11.66% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 11.08% | 11.37% | 11.25% | 11.34% | 11.37% | 10.70% | 10.14% | 10.55% |
| Other Holding | 3.07% | 3.07% | 3.02% | 15.92% | 3.36% | 3.16% | 3.10% | 3.03% |
| Shareholder Count | 65,583 | 71,142 | 64,400 | 36,712 | 36,852 | 40,516 | 38,352 | 60,686 |
Poly Medicure Dividend Screener - Share Yield Analysis
Screen POLYMED dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹3.50 | 0.20% |
| 2024-March | ₹3.00 | 0.13% |
| 2023-March | ₹3.00 | 0.19% |
| 2022-March | ₹2.50 | 0.27% |
| 2021-March | ₹2.50 | 0.26% |
| 2020-March | ₹2.00 | 0.24% |
| 2019-March | ₹2.00 | 0.86% |
| 2018-March | ₹2.00 | 0.91% |
| 2017-March | ₹2.50 | 1.00% |
Poly Medicure Index Membership - Market Screener Classification
Screen POLYMED by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Poly Medicure Market Events Screener - Corporate Actions
Screen POLYMED market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 3.50 /share | -22.75% | ||
| Dividend | ₹ 2.50 /share | -15.72% | ||
| Dividend | ₹ 2.50 /share | 30.39% | ||
| Dividend | ₹ 3.00 /share | 44.66% | ||
| Dividend | ₹ 3.00 /share | 48.83% | ||
| Annual General Meeting | NA | -7.22% | ||
| Annual General Meeting | NA | -4.14% | ||
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -4.08% |
| 2025-08-08 | 2025-08-08 | Quarterly Result Announcement | NA | -6.11% |
| 2025-05-06 | 2025-05-06 | Quarterly Result Announcement | NA | -0.13% |
| 2025-02-03 | 2025-02-03 | Quarterly Result Announcement | NA | -0.46% |
| 2024-10-28 | 2024-10-28 | Quarterly Result Announcement | NA | 2.58% |
| 2017-03-24 | 2017-03-28 | Bonus | 1:1 | - |
Poly Medicure Competitors Screener - Peer Comparison
Screen POLYMED competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 18,253 | 49.99 | 1,759 | 22.62% | 339 | 48.10 |
| Laxmi Dental | 1,420 | 55.00 | 242 | 24.12% | 25 | 39.19 |
| Tarsons Products | 1,212 | 59.48 | 408 | 32.64% | 30 | 40.67 |
| Vasa Denticity | 985 | 66.43 | 173 | % | 15 | 46.60 |
| Osel Devices | 961 | 48.05 | 187 | 40.62% | 20 | 37.82 |
| Fabtech Technologies | 869 | 18.91 | 336 | 45.66% | 47 | 33.93 |
| Prevest Denpro | 612 | 30.05 | 67 | 13.15% | 18 | 60.98 |
| Aprameya Engineering | 464 | 33.00 | 136 | 107.77% | 16 | 24.83 |
| Hemant Surgical Industries | 362 | 47.33 | 112 | % | 8 | 42.35 |
| Nureca | 296 | 72.08 | 122 | 19.24% | 1 | 53.98 |
Poly Medicure Company Announcements - News Screener
Screen POLYMED latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-09 | Clarification On Increase In Volume | View |
| 2026-01-09 | Clarification sought from Poly Medicure Ltd | - |
| 2025-12-31 | Closure of Trading Window | View |
| 2025-12-18 | Investors/Analysts Virtual Call | View |
| 2025-11-22 | Intimation Of Investors/Analyst Virtual Calls | View |
| 2025-11-20 | Intimation Of Investors/Analyst Virtual Call On 24Th November 2025 | View |
| 2025-11-19 | Intimation Of Investotrs/Analyst Virtual Call On 24Th November 2025 | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-12 | Statement Of Deviation & Variation For The Quarter Ended 30Th September 2025 | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Monitoring Agency Report | View |
| 2025-11-11 | Investor/Analyst Calls | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-08 | Declaration Of Unaudited Financial Results For The Second Quarter And Half Year Ended For 30Th September 2025. | View |
| 2025-11-08 | Board Meeting Outcome for Outcome Of Board Meeting Held Hold Today I.E. 08Th November 2025 For Declaration Of Unaudited Financial Results(Standalone & Consolidated) For The Second Quarter And Half Year Ended 30Th September 2025 And For Other Businesses It | View |
| 2025-11-06 | Announcement Under Regulation 30 (LODR)-Updates On Acquisition | View |
| 2025-11-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-31 | Board Meeting Intimation for Notice Of Board Meeting To Be Held On 08Th November 2025. | View |
| 2025-10-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |